Overview

Understanding Disparities in Quitting in African American and White Smokers

Status:
Completed
Trial end date:
2017-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to describe the differences in quitting smoking between African Americans (AA) and White smokers treated with varenicline.
Phase:
Phase 4
Details
Lead Sponsor:
Nikki Nollen, PhD, MA
Collaborators:
National Institute on Drug Abuse (NIDA)
Pfizer
Treatments:
Varenicline